{"id":"https://openalex.org/W7213985462","doi":"https://doi.org/10.1016/j.vaccine.2026.129168","title":"The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000\u20132019","display_name":"The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000\u20132019","publication_year":2026,"publication_date":"2026-09-22","ids":{"openalex":"https://openalex.org/W7213985462","doi":"https://doi.org/10.1016/j.vaccine.2026.129168","pmid":"https://pubmed.ncbi.nlm.nih.gov/42771940"},"language":"en","primary_location":{"id":"doi:10.1016/j.vaccine.2026.129168","doi":"https://doi.org/10.1016/j.vaccine.2026.129168","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2026.129168","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072485453","display_name":"Nick J Andrews","orcid":"https://orcid.org/0000-0003-2069-2684","observed_orcids":["https://orcid.org/0000-0003-2069-2684"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Nick Andrews","raw_affiliation_strings":["Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK. Electronic address: nick.andrews@ukhsa.gov.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK. Electronic address: nick.andrews@ukhsa.gov.uk","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073763711","display_name":"Julia Stowe","orcid":"https://orcid.org/0000-0002-3999-6461","observed_orcids":["https://orcid.org/0000-0002-3999-6461"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Julia Stowe","raw_affiliation_strings":["Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079760484","display_name":"Erjola Hani","orcid":"https://orcid.org/0000-0003-4307-0968","observed_orcids":["https://orcid.org/0000-0003-4307-0968"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Erjola Hani","raw_affiliation_strings":["Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040992001","display_name":"Anna Jeffery-Smith","orcid":"https://orcid.org/0000-0003-2895-7608","observed_orcids":["https://orcid.org/0000-0003-2895-7608"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Jeffery-Smith","raw_affiliation_strings":["Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065434292","display_name":"Mary Elizabeth Ramsay","orcid":"https://orcid.org/0000-0002-7156-7640","observed_orcids":["https://orcid.org/0000-0002-7156-7640"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mary Ramsay","raw_affiliation_strings":["Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London NW9 5EQ, UK","institution_ids":["https://openalex.org/I4387153084"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072485453"],"corresponding_institution_ids":["https://openalex.org/I4387153084"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":{"value":3620,"currency":"USD","value_usd":3620},"fwci":3.8809,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.86583757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"92","issue":null,"first_page":"129168","last_page":"129168"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.1386999934911728,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.0406000018119812,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mmr-vaccine","display_name":"MMR vaccine","score":0.9269999861717224},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7210000157356262},{"id":"https://openalex.org/keywords/vaccine-adverse-events","display_name":"vaccine adverse events","score":0.7059999704360962},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.5759999752044678},{"id":"https://openalex.org/keywords/attributable-risk","display_name":"attributable risk","score":0.5630000233650208},{"id":"https://openalex.org/keywords/england","display_name":"England","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8844000101089478},{"id":"https://openalex.org/C2779771385","wikidata":"https://www.wikidata.org/wiki/Q6132707","display_name":"Thrombocytopenic purpura","level":3,"score":0.6843000054359436},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.6525999903678894},{"id":"https://openalex.org/C2778814567","wikidata":"https://www.wikidata.org/wiki/Q155857","display_name":"Rubella","level":4,"score":0.45910000801086426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3571000099182129},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.3188000023365021},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3082999885082245},{"id":"https://openalex.org/C2779185075","wikidata":"https://www.wikidata.org/wiki/Q7375928","display_name":"Rubella vaccine","level":5,"score":0.3043000102043152},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.301800012588501},{"id":"https://openalex.org/C2909545207","wikidata":"https://www.wikidata.org/wiki/Q908104","display_name":"Measles-Mumps-Rubella Vaccine","level":5,"score":0.3005000054836273},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.29580000042915344},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.2953999936580658},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.26930001378059387},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.26899999380111694},{"id":"https://openalex.org/C986699","wikidata":"https://www.wikidata.org/wiki/Q7939","display_name":"El Ni\u00f1o","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2515999972820282}],"mesh":[{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004739","descriptor_name":"England","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009107","descriptor_name":"Mumps","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012409","descriptor_name":"Rubella","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D022542","descriptor_name":"Measles-Mumps-Rubella Vaccine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D022542","descriptor_name":"Measles-Mumps-Rubella Vaccine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.vaccine.2026.129168","doi":"https://doi.org/10.1016/j.vaccine.2026.129168","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2026.129168","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},{"id":"pmid:42771940","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42771940","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.vaccine.2026.129168","doi":"https://doi.org/10.1016/j.vaccine.2026.129168","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2026.129168","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213985462.pdf","grobid_xml":"https://content.openalex.org/works/W7213985462.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1486224385","https://openalex.org/W1595426738","https://openalex.org/W1917716118","https://openalex.org/W1971596777","https://openalex.org/W1973056712","https://openalex.org/W2046727720","https://openalex.org/W2097591338","https://openalex.org/W2157328456","https://openalex.org/W2170831647","https://openalex.org/W3004938146","https://openalex.org/W3082385510","https://openalex.org/W3130055273","https://openalex.org/W4225341318","https://openalex.org/W4412649885"],"related_works":["https://openalex.org/W2170831647","https://openalex.org/W1486224385","https://openalex.org/W7098786743","https://openalex.org/W1917716118","https://openalex.org/W4412649885","https://openalex.org/W7122499536","https://openalex.org/W2007741934","https://openalex.org/W2150347177","https://openalex.org/W2063655568","https://openalex.org/W2157328456"],"abstract_inverted_index":{"We":[0,54,72,97],"assessed":[1,56],"the":[2,39,45,49,57,118,136],"risk":[3,58,76,91,104,134],"of":[4,59,77,92,101],"Idiopathic":[5],"thrombocytopenic":[6],"purpura":[7],"(ITP)":[8],"after":[9,61,69,79,105,123,138],"Measles":[10],"Mumps":[11],"Rubella":[12],"vaccine":[13,35],"(MMR)":[14],"doses":[15],"1":[16,81,93,125],"and":[17,141],"2":[18,63,107,130],"in":[19,21,48,64,94,135],"children":[20,120],"England":[22],"born":[23],"from":[24],"2000":[25],"to":[26,33,43,147],"2019.":[27],"After":[28],"linking":[29],"hospitalised":[30],"ITP":[31,60,68,78,122],"episodes":[32],"MMR":[34,128],"records,":[36],"we":[37,115],"used":[38],"self-control":[40],"case-series":[41],"method":[42],"assess":[44],"relative":[46],"incidence":[47,83,109],"6-week":[50],"period":[51],"post":[52],"vaccination.":[53],"also":[55],"dose":[62,70,80,106,124,129,140],"those":[65],"who":[66,126],"had":[67,127,131],"1.":[71],"found":[73,98,116],"an":[74,89,102],"increased":[75,103,133],"(relative":[82,108],"2.38":[84],"(95%":[85,111],"CI:":[86,112],"2.12-2.67))":[87],"with":[88,121],"attributable":[90],"42,900":[95],"doses.":[96],"no":[99,132],"evidence":[100],"0.96":[110],"0.81-1.13)).":[113],"Furthermore,":[114],"that":[117,142],"336":[119],"6-weeks":[137],"this":[139],"it":[143],"is":[144],"therefore":[145],"safe":[146],"vaccinate":[148],"these":[149],"children.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-09-22T00:00:00"}